• Privacy Policy
  • Terms and Conditions

© 2026 Sciad

  • Our Expertise
    • Design
      • Ads & Social Graphics
      • Branding
      • Marketing Assets
      • Video & Animation
      • Website Design & Development
    • Digital Marketing
      • Conversion Rate Optimisation
      • Digital Analytics & Reporting
      • Digital Marketing Strategy
      • Digital Press Office
      • Email Marketing
      • Lead Generation
      • PPC Marketing
      • SEO Services
      • Social Media Marketing
    • PR & Communications
      • Brand Positioning & Key Messaging
      • Communications Strategy
      • Conferences & Event Support
      • Media Relations
      • Reputation Management
      • Thought Leadership
  • Sectors
    • Digital Health
    • Engineering
    • Healthcare, Diagnostics & Medical Devices
    • Laboratory Instruments & Suppliers
    • Life Science & Biotech
    • Pharmaceuticals & Medicine
    • Science
    • Science & Healthcare Charities
    • Science Publishing & Academic Collaboration
    • Synthetic Biology
    • Med Tech
  • Our Work
  • News
  • About Us
    • Our Team
    • Careers
  • Contact Us
  • Professors Jay Keasling and Chris Voigt Announced as Keynote Speakers at the SynbiCITE & IET Engineering Biology Conference

    Professors Jay Keasling and Chris Voigt Announced as Keynote Speakers at the SynbiCITE & IET Engineering Biology Conference

    The 1st International Conference on Engineering Biology, co-founded by the pioneering National Industrial Translation Centre for Synthetic Biology – SynbiCITE – and the Institution of Engineering and Technology (IET), has announced world experts Professor Jay Keasling and Professor Chris Voigt as keynote speakers, as well as a range of other international speakers.

    November 1, 2016
  • ReViral Initiates Phase 1 Clinical Trial of Potent Oral Inhibitor Against Respiratory Syncytial Virus

    ReViral Initiates Phase 1 Clinical Trial of Potent Oral Inhibitor Against Respiratory Syncytial Virus

    ReViral, an antiviral drug discovery and development company developing innovative therapies against Respiratory Syncytial Virus (RSV), announced today the initiation of a Phase 1 clinical trial for RV521, its novel orally-active small molecule inhibitor of RSV fusion.

    October 31, 2016
  • The Four Pillars of Healthcare Valuation

    The Four Pillars of Healthcare Valuation

    Salt Lake City, USA, 14th October 2016 / Sciad Newswire / The Institute for Healthcare Valuation (IHV) and Consultants’ Training Institute (CTI) are pleased to announce premier healthcare valuation training through a distance education program, the Certificate of Educational Achievement (CEA) for Advanced Education in Healthcare Valuation. The program will launch in the summer of 2017 and will bridge the…

    October 26, 2016
  • The RSA Group appoints Natalie Walter as new NED to its Board

    The RSA Group appoints Natalie Walter as new NED to its Board

    London, UK, 25th October 2016 / Sciad Newswire / The RSA Group, the world’s largest Talent Consultancy in Life Sciences, has announced the appointment of Natalie Walter as a Non-Executive Director to its Board. She will join the Board with immediate effect. Natalie is a Corporate Partner in the life sciences practice at Covington, a leading global law…

    October 25, 2016
  • NALIA Systems Expands Board and Management Team

    NALIA Systems Expands Board and Management Team

    NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, announces the expansion of its board following the recent successful £500,000 fund raising.

    October 24, 2016
  • NALIA Systems Closes Oversubscribed Investment Round Through Syndicate Room

    NALIA Systems Closes Oversubscribed Investment Round Through Syndicate Room

    London, UK, 18th October 2016 / Sciad Newswire / NALIA Systems, a developer of novel multiplex immunodiagnostic systems for clinical and research applications, has succeeded in raising £500,000 from Syndicate Room and its own investor network, exceeding fundraising targets by 25%. The funding will enable prototype development for a multi-biomarker diagnostic device, as well as a series of…

    October 18, 2016
  • The RSA Group appoints Thomas Schleimer as new Partner

    The RSA Group appoints Thomas Schleimer as new Partner

    London, UK, 18th October 2016 / Sciad Newswire / The RSA Group – the world’s largest talent consultancy in life sciences – announces the appointment of Thomas Schleimer as a Partner.  Formerly a Managing Partner with a well-known life sciences executive search boutique, Thomas has led teams in executive search and industry for over 25 years with experience in…

    October 18, 2016
  • Success of future health systems hinges on access to data, say experts

    Success of future health systems hinges on access to data, say experts

    Cambridge, UK, 18th October 2016 / Sciad Newswire / An international group of population health experts is calling for sharing of health data to be the norm if precision health agendas are to succeed and build sustainable health systems. Key messages Health systems are failing citizens and need radical revamp Success of precision health agenda hinges on data…

    October 18, 2016
  • “Healthcare systems must adapt to cope with escalating impact of ageing populations” says President of leading global healthcare organisation

    “Healthcare systems must adapt to cope with escalating impact of ageing populations” says President of leading global healthcare organisation

    Dublin, Ireland, 17th October 2016 / Sciad Newswire / Professor Clifford Hughes was speaking in anticipation of the publication of a White Paper published by the International Journal for Quality in Health Care (ISQua) today which discusses the impact of current and impending pressure of ageing populations which will present significant planning and budgetary challenges for global healthcare systems….

    October 17, 2016
  • European life sciences sector embraces home-working: 37% work from home at least once a week

    European life sciences sector embraces home-working: 37% work from home at least once a week

    According to new research from specialist recruiter Hobson Prior, home-working is growing ever more popular in the life sciences sector: 32% of professionals surveyed have seen an increase in the number of home-working opportunities available.

    October 11, 2016
←Previous Page
1 … 58 59 60 61 62 … 80
Next Page→

We have all the tools to bring your innovation to life.

    • LinkedIn
    • X
Our Expertise
  • Design
  • Digital Marketing
  • PR & Communications
About Us
  • About Sciad
  • Our Team
  • Careers
Contact Us

hello@sciad.com

+44 (0)20 3405 7892

  • Privacy Policy
  • Terms & Conditions

© 2026 Sciad Communications